coronary artery disease
Conditions
Interventions
1. blood test 2. intravascular ultrasonography 3. endothelial function test
Sponsors
Chiba University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patient who will undergo percutaneous coronary intervention with NIRS-IVUS in our hospital
Exclusion criteria
Exclusion criteria: 1. patients undergoing hemodialysis 2. patients taking inhibitor of xanthine oxidoreductase 3. patients who are not eligible by the investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relation between xanthine oxidoreductase reactivity and coronary lipid plaque with NIRS-IVUS | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Relation between xanthine oxidoreductase reactivity and endothelial function with Endo-PAT 2. Distribution of xanthine oxidoreductase reactivity in coronary artery disease 3. Relation between xanthine oxidoreductase reactivity and uric acid 4. Relation between xanthine oxidoreductase reactivity and coronary plaque volume 5. Relation between purine bodies (hypoxanthine, xanthine) and coronary lipid plaque 6. Relation between purine bodies (hypoxanthine, xanthine) and endothelial function 7. Relation between uric acid and coronary plaque or endothelial function | — |
Countries
Japan
Contacts
Public ContactYuichi Saito
Chiba University Hospital Department of Cardiovascular Medicine
Outcome results
None listed